Bhubaneswar: Odisha is all set to establish a vaccine manufacturing unit at Andharua on the outskirts of Bhubaneswar.
The vaccine unit will be set up by Hyderabad-based Bharat Biotech International Limited (BBIL). The unit will produce 10 types of vaccines including that of COVID-19 and malaria, the total investment would be around Rs 300 crore.” informs Chief Secretary Asit Tripathy informed during a meeting.
The anchor developer to set up a state of the art biotech incubation centre, common facilities and IT corridor along with the first phase construction of the project.The company was also requested to promote local start-ups, informed Chief Secretary.
The land is available in the Biotech Park at Andharua for ground-breaking and the building plan has also been approved. The Chief Secretary directed that the ground level construction work should be started within a fortnight and production should commence within the scheduled time.
The company will start the production and development of new or improved vaccines for diarrhea,malaria, Japanese Encephalitis and pandemic influenza, informs Chairman and managing director of BBIL, Krishna Ella.
Ms Kalinga